Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology
While therapeutic drug monitoring (TDM) that uses blood as the biological matrix is the traditional gold standard, this practice may be impossible, impractical, or unethical for some patient populations (e.g., elderly, pediatric, anemic) and those with fragile veins. In the context of finding an alt...
Main Authors: | Tony K.L. Kiang, Sahan A. Ranamukhaarachchi, Mary H.H. Ensom |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/9/4/43 |
Similar Items
-
Microneedle Arrays for Sampling and Sensing Skin Interstitial Fluid
by: Navid Kashaninejad, et al.
Published: (2021-04-01) -
Biosensing in dermal interstitial fluid using microneedle based electrochemical devices
by: Julia Madden, et al.
Published: (2020-08-01) -
Functionalized microneedles for continuous glucose monitoring
by: Kai Takeuchi, et al.
Published: (2018-10-01) -
Minimally Invasive Glucose Monitoring Using a Highly Porous Gold Microneedles-Based Biosensor: Characterization and Application in Artificial Interstitial Fluid
by: Paolo Bollella, et al.
Published: (2019-06-01) -
Microneedling therapy in atrophic facial scars: An objective assessment
by: Majid Imran
Published: (2009-01-01)